Quarter Financials
Newron Pharmaceuticals SpA (NP5.DE)
3.15 €
+0.01 (+0.32%)
Income Statement
Balance Sheet
Cash Flow
|
Year
|
2022 Q2
|
2021 Q4
|
2021 Q2
|
2020 Q4
|
2020 Q2
|
2019 Q4
|
2019 Q2
|
2018 Q4
|
|---|
| Net Income | - | - | - | - | - | - | -5 | - |
|---|
| Dividend Paid | - | - | - | - | - | - | - | - |
|---|
| Retained Earnings | -14 | -20 | -14 | -26 | -16 | -25 | -19 | -20 |
|---|
|
Year
|
2022 Q2
|
2021 Q4
|
2021 Q2
|
2020 Q4
|
2020 Q2
|
2019 Q4
|
2019 Q2
|
2018 Q4
|
|---|
| Capital Expenditure | - | - | - | - | - | - | -0 | - |
|---|
| Net PPE | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
|---|
|
Year
|
2022 Q2
|
2021 Q4
|
2021 Q2
|
2020 Q4
|
2020 Q2
|
2019 Q4
|
2019 Q2
|
2018 Q4
|
|---|
| New Purchases | - | -1 | - | - | - | - | - | - |
|---|
| Intangible and Goodwill | - | - | - | - | - | - | - | - |
|---|